Melanoma, cutaneous malignant, susceptibility to, 8: genes and variants
Explore variant evidence for Melanoma, cutaneous malignant, susceptibility to, 8 across 6 analyzed proteins (CDKN2A, STK11, MITF, CDK4, TERT and 1 more). Linked ClinVar records include 12 pathogenic or likely pathogenic variants, 320 variants of uncertain significance and 54 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Melanoma, cutaneous malignant, susceptibility to, 8
CDKN2A: Tumor suppressor ARF
The ARF product of CDKN2A is a tumor-suppressor protein that binds MDM2 and helps preserve p53 activity. By promoting cell-cycle arrest and apoptosis, it provides an important barrier to uncontrolled cell growth from within the nucleolus.
6 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in CDKN2A have source records linked to Melanoma, cutaneous malignant, susceptibility to, 8. Association strength is not clinical gene validity.
STK11: Serine/threonine-protein kinase STK11
It activates AMPK-family kinases to coordinate cellular energy sensing, polarity, and growth restraint. Germline loss-of-function variants cause Peutz-Jeghers syndrome and its associated cancer predisposition, while somatic loss is common in lung and other cancers.
4 ClinVar pathogenic / likely pathogenic and 88 uncertain variants in STK11 have source records linked to Melanoma, cutaneous malignant, susceptibility to, 8. Association strength is not clinical gene validity.
MITF: Microphthalmia-associated transcription factor
A transcription factor that drives melanocyte survival, pigment production, and melanosome formation. Pathogenic variants can cause Waardenburg syndrome type 2A or Tietz syndrome.
2 ClinVar pathogenic / likely pathogenic and 227 uncertain variants in MITF have source records linked to Melanoma, cutaneous malignant, susceptibility to, 8. Association strength is not clinical gene validity.
CDK4: Cyclin-dependent kinase 4
Together with D-type cyclins, it phosphorylates RB-family proteins and commits cells to progress from G1 toward DNA replication. Amplification or pathway activation is common in cancer, while rare activating germline variants predispose to familial melanoma.
0 ClinVar pathogenic / likely pathogenic and 17 uncertain variants in CDK4 have source records linked to Melanoma, cutaneous malignant, susceptibility to, 8. Association strength is not clinical gene validity.
TERT: Telomerase reverse transcriptase
It extends telomeric DNA using an internal RNA template and helps counter progressive chromosome-end shortening in stem and proliferative cells. Loss-of-function variants cause telomere-biology disorders, while promoter activation and increased activity support unlimited proliferation in many cancers.
0 ClinVar pathogenic / likely pathogenic and 14 uncertain variants in TERT have source records linked to Melanoma, cutaneous malignant, susceptibility to, 8. Association strength is not clinical gene validity.
BRAF: Serine/threonine-protein kinase B-raf
It relays activated RAS signals through MEK and ERK to control proliferation, differentiation, and survival. Activating variants, especially V600E, drive melanoma and several other cancers and create sensitivity to pathway-directed therapies.
0 ClinVar pathogenic / likely pathogenic and 19 uncertain variants in BRAF have source records linked to Melanoma, cutaneous malignant, susceptibility to, 8. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Melanoma, cutaneous malignant, susceptibility to, 8
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| STK11 G163R | 163 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| CDKN2A V46G | 46 | Interaction with CDK5RAP3 and MDM2 | Pathogenic / likely pathogenic (★★) |
| CDKN2A R115L | 115 | Pathogenic / likely pathogenic (★★) | |
| MITF L318P | 318 | bHLH | Pathogenic / likely pathogenic (★★) |
| CDKN2A S52I | 52 | Interaction with CDK5RAP3 and MDM2 | Pathogenic / likely pathogenic (★★) |
| CDKN2A Q70H | 70 | Pathogenic / likely pathogenic (★★) | |
| CDKN2A R87P | 87 | Pathogenic / likely pathogenic (★★) | |
| STK11 W308L | 308 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| MITF E425K | 425 | DNA-binding regulation | Pathogenic / likely pathogenic (★★) |
| CDKN2A S73R | 73 | Pathogenic / likely pathogenic (★★) | |
| STK11 Y49D | 49 | Protein kinase | Pathogenic / likely pathogenic |
| STK11 G135R | 135 | Protein kinase | Pathogenic / likely pathogenic |
Which prediction tools work for Melanoma, cutaneous malignant, susceptibility to, 8
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- PolyPhen-2: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 79 out of 100
- ESM1b (LLR): 70 out of 100
Same protein, different disease
- Familial melanoma also has ClinVar records linked to CDKN2A variants; they fall mostly in different places as the Melanoma, cutaneous malignant, susceptibility to, 8 variants (15 pathogenic / likely pathogenic).
- Melanoma-pancreatic cancer syndrome also has ClinVar records linked to CDKN2A variants; they fall partly in the same places as the Melanoma, cutaneous malignant, susceptibility to, 8 variants (11 pathogenic / likely pathogenic).
- Melanoma and neural system tumor syndrome also has ClinVar records linked to CDKN2A variants; they fall partly in the same places as the Melanoma, cutaneous malignant, susceptibility to, 8 variants (5 pathogenic / likely pathogenic).
- Peutz-Jeghers syndrome also has ClinVar records linked to STK11 variants; they fall mostly in different places as the Melanoma, cutaneous malignant, susceptibility to, 8 variants (24 pathogenic / likely pathogenic).
- Waardenburg syndrome also has ClinVar records linked to MITF variants; they fall mostly in different places as the Melanoma, cutaneous malignant, susceptibility to, 8 variants (10 pathogenic / likely pathogenic).
Diseases related to Melanoma, cutaneous malignant, susceptibility to, 8
- Lung adenocarcinoma, also linked to BRAF, CDKN2A, STK11 and TERT
- Familial melanoma, also linked to CDK4, CDKN2A and TERT
- Non-small cell lung carcinoma, also linked to BRAF, CDKN2A and STK11
- Hepatocellular carcinoma, also linked to BRAF, CDKN2A and TERT
- Melanoma, also linked to BRAF, CDKN2A and MITF
- Alzheimer disease, also linked to CDK4 and CDKN2A
- Urinary bladder cancer, also linked to CDKN2A and TERT
- Parkinson disease, also linked to CDK4 and CDKN2A
- Lung carcinoma, also linked to BRAF and TERT
- Hypertrophic cardiomyopathy, also linked to BRAF
- RASopathy, also linked to BRAF
- Noonan syndrome, also linked to BRAF
Frequently asked questions
Which genes have records linked to Melanoma, cutaneous malignant, susceptibility to, 8?
This view contains 6 analyzed proteins: CDKN2A, STK11, MITF, CDK4, TERT and 1 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 12 pathogenic or likely pathogenic variants, 320 variants of uncertain significance and 54 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 412 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center